Microglia Activation/Proliferation
Showing 26 - 50 of 6,585
Mastocytosis Trial in Toulouse (Hydroxychloroquine)
Not yet recruiting
- Mastocytosis
-
Toulouse, FranceLarrey Hospital - Toulouse University Hospital
Oct 6, 2021
Does Microglial Activation Promote Lesion Growth and Progression
Enrolling by invitation
- Multiple Sclerosis
-
Turku, Finland Proper, FinlandTurku PET Centre
Nov 1, 2022
NSCLC Trial in Rotterdam (Nutritional intervention, Immunotherapy)
Recruiting
- Non-small Cell Lung Cancer
- Nutritional intervention
- Immunotherapy
-
Rotterdam, NetherlandsErasmus MC
Jun 5, 2023
Lower Limb Fracture, Nerve Block Trial in Beijing (Dexmedetomidine, Midazolam)
Completed
- Lower Limb Fracture
- Nerve Block
-
Beijing, Beijing, ChinaChina International Neuroscience
Aug 4, 2021
Osteosarcoma Trial in United States (Avelumab, Questionnaires)
Active, not recruiting
- Osteosarcoma
- Avelumab
- Questionnaires
-
Los Angeles, California
- +3 more
Aug 22, 2022
TCR-T Cells, Refractory Solid Tumors, Relapsed Solid Tumors Trial in Nanning (KSH01 injection)
Recruiting
- TCR-T Cells
- +2 more
- KSH01 injection
-
Nanning, Guang XI, ChinaThe first affiliated hospital of Guang Xi medical university
Sep 14, 2022
Retroperitoneal Fibrosis Trial in Beijing (Sirolimus, Corticosteroid)
Recruiting
- Retroperitoneal Fibrosis
-
Beijing, Beijing, ChinaPeking University International Hospital
Dec 7, 2022
Non Small Cell Lung Cancer, EGFR Gene Mutation, Immune Checkpoint Inhibitor Trial in Jerusalem (concomitant TTFields treatment
Not yet recruiting
- Non Small Cell Lung Cancer
- +2 more
- concomitant TTFields treatment device to standard of care EGFR positive NSCLC treatment
- concomitant TTFields treatment device to standard of care anti PD-1 NSCLC treatment
-
Jerusalem, IsraelShaare Zedek Medical Center
Jan 22, 2023
Advanced Cancer Trial in Chengdu, Hangzhou (TQB2223 injection+ Penpulimab Injection)
Recruiting
- Advanced Cancer
- TQB2223 injection+ Penpulimab Injection
-
Chengdu, Sichuan, China
- +1 more
Jun 7, 2023
Liver Fibrosis Trial in Tehran (Imatinib 200mg, Placebo)
Active, not recruiting
- Liver Fibrosis
- Imatinib 200mg
- Placebo
-
Tehran, Iran, Islamic Republic ofResearch Institute of Gastroenterology & Liver Diseases
Jan 24, 2022
Relapsing Multiple Sclerosis Trial in Boston (Ofatumumab, [F-18]PBR06)
Recruiting
- Relapsing Multiple Sclerosis
-
Boston, MassachusettsPartners MS Center, 60 Fenwood Road
Jul 20, 2021
HLA-DR in Cell Cultures Isolated From Primary Squamous Cell
Active, not recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Cancer
- cell culture
-
Roma, Lazio, ItalyFondazione Policlinico Universitario Gemelli, Irccs
Sep 11, 2023
Macrophages Activation Pattern in X-linked Adrenoleukodystrophy,
Recruiting
- Adrenoleukodystrophy
- +3 more
- Blood sample collection
-
Le Kremlin-Bicêtre, France
- +1 more
Oct 10, 2022
Obesity Trial in New Haven (Intralipid Infusion)
Not yet recruiting
- Obesity
- Intralipid Infusion
-
New Haven, ConnecticutYale University
Oct 5, 2022
ALS Trial ([11C]CPPC PET ligand)
Not yet recruiting
- ALS
- [11C]CPPC PET ligand
- (no location specified)
Jan 9, 2023
Using IMC to Analyze the Impact of ICANS on Microglia
Recruiting
- ICANS, Grade Unspecified
- CAR T-Cell-Related Encephalopathy Syndrome
- There will be no intervention as we will study patients that undergo autopsy after CAR T cell infusion.
-
Freiburg, Baden Württemberg, GermanyFreiburg University Medical Center
Apr 12, 2023
Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Detroit (Laboratory Biomarker
Active, not recruiting
- Invasive Breast Carcinoma
- +6 more
- Laboratory Biomarker Analysis
- Simvastatin
-
Detroit, MichiganWayne State University/Karmanos Cancer Institute
Jun 17, 2022
DALY on a Cohort of Patients With Indolent Systemic Mastocytosis
Recruiting
- Mastocytosis, Indolent Systemic
-
Toulouse, Haute-Garonne, FranceCentre de Référence des Mastocytoses, Service de Dermatologie, H
Jun 19, 2023
Link Between Complement Activation and IgA Nephropathy Severity
Recruiting
- IgA Nephropathy Severity in Kidney Transplantation
- IgAN patients
-
Strasbourg, FranceService de néphrologie
Aug 18, 2022
Breast Cancer, Breast Tumors, Cancer of Breast Trial in New York (Metformin, Atorvastatin, Breast surgery)
Active, not recruiting
- Breast Cancer
- +2 more
- Metformin
- +2 more
-
New York, New YorkColumbia University Medical Center - Herbert Irving Cancer Cente
Aug 16, 2022
Formyl Peptide Receptor 1 With Sepsis-related Encephalopathy
Not yet recruiting
- Sepsis-Associated Encephalopathy
-
Yinchuan, Ningxia, ChinaDepartment of Anesthesiology, General Hospital of Ningxia Medica
Jul 8, 2022
Fibrosis Trial in Aarhus (Growth hormone, saline and GH receptor blockade (Pegvisomant))
Recruiting
- Fibrosis
- Growth hormone, saline and GH receptor blockade (Pegvisomant)
-
Aarhus, DenmarkAarhus University
Aug 31, 2021
MDD Trial (SSRI + golimumab, SSRI + )
Not yet recruiting
- Major Depressive Disorder
- SSRI + golimumab
- SSRI + placebo
- (no location specified)
Aug 25, 2020
Schizophrenia Trial in London (Natalizumab, Placebo: normal saline)
Recruiting
- Schizophrenia
- Natalizumab
- Placebo: normal saline
-
London, United KingdomInstitute of Psychiatry, Psychology and Neuroscience, King's Col
Sep 27, 2022
Ischemic Stroke, Acute Trial (Minocycline HCl capsule, Placebo capsules of Minocycline HCl capsules)
Not yet recruiting
- Ischemic Stroke, Acute
- Minocycline hydrochloride capsule
- Placebo capsules of Minocycline hydrochloride capsules
- (no location specified)
Apr 19, 2023